Inflammatix
Inflammatix is a biotech company focused on developing rapid diagnostic tests that utilize machine learning to assess immune responses for detecting acute infections and sepsis.
Company Overview
Inflammatix is focused on developing rapid tests that analyze the immune system to address significant clinical and public health issues. The company's primary objective centers on acute bacterial and viral infections and sepsis. By leveraging proprietary machine-learning algorithms, Inflammatix creates diagnostics capable of delivering clinically actionable results swiftly.
Products in Development
Inflammatix is developing several products, including TriVerity™ and BacVerity™, which target the diagnosis of acute infections and sepsis. TriVerity™ is designed specifically for emergency departments to assess adult patients with suspected acute infections or sepsis. Both products are currently not for sale and lack marketing approval or clearance from regulatory authorities.
FDA Breakthrough Device Designation
TriVerity™, Inflammatix's test system aimed at emergency departments, has received Breakthrough Device Designation from the FDA. This designation is intended to expedite the development and review of medical devices that offer better treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions.
Machine-Learning Algorithms in Diagnostics
Inflammatix employs proprietary machine-learning algorithms to enhance the diagnostic process. These algorithms focus on generating clinically actionable results from rapid diagnostics by measuring the patient's immune response to bacteria and viruses. The research involves areas such as hyperparameter optimization and fairness in diagnostics to improve diagnostic accuracy and efficiency.
Advocacy for Antimicrobial Stewardship
Inflammatix actively participates in advocacy efforts for antimicrobial stewardship and combating antimicrobial resistance. These efforts are crucial in addressing the growing public health challenge of antibiotic-resistant infections, ensuring that antimicrobial medications are used judiciously and effectively.